CTI BIOPHARMA CORP 4
4 · CTI BIOPHARMA CORP · Filed Feb 26, 2016
Insider Transaction Report
Form 4
SINGER JACK W
EVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2016-02-26$0.61/sh−100$62→ 1,054,892 total - Sale
Common Stock
2016-02-26$0.62/sh−300$185→ 1,054,592 total - Sale
Common Stock
2016-02-26$0.62/sh−200$124→ 1,054,392 total - Sale
Common Stock
2016-02-26$0.62/sh−510$317→ 1,053,882 total - Sale
Common Stock
2016-02-26$0.62/sh−100$62→ 1,053,782 total - Sale
Common Stock
2016-02-26$0.62/sh−200$125→ 1,053,582 total - Sale
Common Stock
2016-02-26$0.63/sh−200$125→ 1,053,382 total - Sale
Common Stock
2016-02-26$0.63/sh−300$189→ 1,053,082 total - Sale
Common Stock
2016-02-26$0.63/sh−100$63→ 1,052,982 total - Sale
Common Stock
2016-02-26$0.63/sh−600$380→ 1,052,382 total - Sale
Common Stock
2016-02-26$0.63/sh−3,990$2,530→ 1,048,392 total - Sale
Common Stock
2016-02-26$0.64/sh−600$381→ 1,047,792 total - Sale
Common Stock
2016-02-26$0.64/sh−1,130$719→ 1,046,662 total - Sale
Common Stock
2016-02-26$0.64/sh−2,600$1,656→ 1,044,062 total - Sale
Common Stock
2016-02-26$0.64/sh−3,270$2,086→ 1,040,792 total - Sale
Common Stock
2016-02-26$0.64/sh−200$128→ 1,040,592 total - Sale
Common Stock
2016-02-26$0.64/sh−100$64→ 1,040,492 total - Sale
Common Stock
2016-02-26$0.64/sh−500$322→ 1,039,992 total
Footnotes (1)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan.